
The ONS Podcast
- Format:
- Podcast
- New episodes:
- Weekly
- Typical length:
- about 35 minutes
- Latest episode:
About this show
Where ONS Voices Talk Cancer
Join oncology nurses on the Oncology Nursing Society's award-winning podcast as they sit down to discuss the topics important to nursing practice and treating patients with cancer.
ISSN 2998-2308
Covers: oncology nursing, cancer care, cancer treatment, patient education, precision oncology, oncologic emergencies, hematologic cancers, nursing leadership
Show details and episodes come from the publisher's public feed at rss.libsyn.com. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
The ONS Podcast, from the Oncology Nursing Society, has oncology nurses discussing cancer care topics that matter to nursing practice and patients. Recent episodes cover biomarker testing, reframing care at end of life, inpatient rehabilitation during cancer treatment, Hodgkin lymphoma, and oncologic emergencies such as hypersensitivity reactions.
Cosmos
Similar by topic and creator
- Good Sleep: Positive Affirmations
Shares the topics Education and Health. - The Dad Edge Podcast
Shares the topics Education and Health. - Sleep Magic: Sleep Hypnosis & Meditation for Sleep Podcast
Shares the topics Education and Health.
Similar shows
- The Organic Chemistry Tutor
- The Organized Coach - Productivity, Business Systems, Time Management, ADHD, Routines, Life Coach, Entrepreneur
- The Orvis Fly-Fishing Podcast
- The Other Side NDE (Near Death Experiences)
- The Overwhelmed Brain
- The Par Train | Get Off the Struggle Bus
- The Parrot Podcast
- The Paul Parent Garden Club
Explore more
Episodes
Episode 441: Care Coordination and Patient Education in Biomarker Testing
· 13 min
"A lot of people are worried if they wait a week that somehow their disease is going to get out of control and become worse. That's a common fear for anyone with cancer. I think that any delay makes them nervous. So just reassuring them that the time it takes to get biomarkers will not harm them and will actually be beneficial in hopefully providing targeted therapy for their disease to give them the best outcome possible," ONS member Becky Sousa, MSN, RN, OCN®, AMB-BC, nurse coordinator at the Women's Cancer Center Gyn-Oncology Stanford Hospitals and Clinics in California, told Katie Hubbard, MSN, RN, OCN®, NPD-BC, oncology clinical specialist at ONS, during a conversation about care coordination for biomarker testing. This podcast episode was produced by ONS and is sponsored by AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes - This episode is not eligible for NCPD contact hours. - ONS Podcast™ episodes: - Episode 437: Precision Oncology: What We've Learned and What's Ahead (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-437-precision-oncology-what-weve-learned-and-whats-ahead) - Episode 406: Drug Resistance Biomarkers and Their Impact on Cancer Treatment Choices (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-406-drug-resistance-biomarkers-and-their-impact) o Episode 389: Biomarker Testing for Non-Small Cell Lung Cancer (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-389-biomarker-testing-non-small-cell-lung-cancer) o Episode 373: Biomarker Testing in Prostate Cancer (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-373-biomarker-testing-prostate-cancer) o Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-169-how-biomarker-testing-drives-use-targeted) - ONS Voice articles: - Case Study: Oncology Nurses' Role in Precision Care Coordination (https://www.ons.org/publications-research/voice/news-views/08-2026/case-study-oncology-nurses-role-precision-care-coordination) o Help Your Patients Understand Biomarker Resistance Testing (https://www.ons.org/publications-research/voice/news-views/01-2026/help-your-patients-understand-biomarker-resistance) o Key Patient Education Points for Biomarker Resistance Testing (https://www.ons.org/publications-research/voice/news-views/01-2026/key-patient-education-points-biomarker-resistance) - 9 Tips for Talking to Patients About Biomarker Testing (https://www.ons.org/publications-research/voice/news-views/08-2026/9-tips-talking-patients-about-biomarker-testing) - Oncology Nurses Coordinate Precision Care, From Test Order to Treatment (https://www.ons.org/publications-research/voice/news-views/08-2026/oncology-nurses-coordinate-precision-care-test-order-treatment) - Preventing Errors in Germline Biomarker Testing Is Everyone's Responsibility (https://www.ons.org/publications-research/voice/news-views/10-2026/preventing-errors-germline-biomarker-testing-everyones-responsibility) - ONS book: Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum (https://www.ons.org/store/books/oncology-nurse-navigation-delivering-patient-centered-care-across-continuum-third) (third edition) - Clinical Journal of Oncology Nursing article: Using Nurse Navigators to Improve Timeliness of Biomarker Testing for Non-Small Cell Lung Cancer (https://doi.org/10.1188/24.CJON.589-592) - ONS Biomarker Guides™ (https://www.ons.org/clinical-tools/biomarkers) - OncoLink: Patient Guide to Tumor Markers (https://www.oncolink.org/cancer-treatment/procedures-diagnostic-tests/blood-tests-tumor-diagnostic-tests/patient-guide-to-tumor-markers) - National Cancer Institute:…
Not rated yetEpisode 440: Reframing Death in Terminal Cancer Care
· 27 min
"Patients often fear that when the treatment stops, the caring will stop as well. It is so important to remind the patients we're serving that we're not stopping the care. We're just changing our focus and prioritizing things differently. We're still treating pain, we're managing symptoms, and we're helping them achieve the goals that matter most to them. The care doesn't go away. In many ways, it becomes even more personalized and supportive," ONS member Julia Proshwitz, BSN, RN, OCN®, NPD–BC, clinical educator of inpatient and outpatient oncology services, infusion, and vascular access at Corewell Health in Saint Joseph, MI, told Madeline Johnston, MSN, RN, OCN®, oncology clinical specialist at ONS, during a conversation about reframing death in terminal cancer care. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 6, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to caring for people with terminal cancer. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care - Episode 257: Redefining the Bell: The Ethics of Hope for Oncology Nurses and Patients - Episode 251: Palliative Care Programs for Patients With Cancer - Episode 135: ELNEC Has Trained More Than One Million Nurses in End-of-Life Care - ONS Voice articles: - By Fulfilling 49 Patient Wishes, One Unit Improves Both EOL Care and Healthcare Workers' Well-Being - Communication Is Essential to End-of-Life Choices - End-of-Life Care Helps Patients Pursue Purpose in the Presence of Pain - When the Story Ends, Cancer Does Not Win: Reframing Death in Terminal Cancer Care - Writing Condolence Cards Supports Nurses as Well as Deceased Patients' Families - Clinical Journal of Oncology Nursing articles: - Clinical Oncology Nurse Best Practices: Palliative Care and End-of-Life Conversations - Elevating End-of-Life Care: Implementing General Inpatient Hospice Services on a Medical Oncology Unit - Enhancing Nurses' Comfort and Capability With End-of-Life Care for Patients With Cancer - Promoting End-of-Life Care and Healthcare Worker Well-Being: Implementing the 3 Wishes Project in an Oncology Intensive Care Unit - Oncology Nursing Forum article: Exploring Information Needs of Patients With Cancer and Family Caregivers: A Descriptive and Network Analysis of End-of-Life Inquiries - ONS Huddle Card: Palliative and Hospice Care - Being Mortal (https://atulgawande.com/book/being-mortal/) by Atul Gawande - Center to Advance Palliative Care: Palliative Care in Cancer Care - End-of-Life Nursing Education Consortium: Resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Cancer isn't always something that people can overcome and it's not always with determination alone. There are many patients who can do everything right. They've showed up with incredible courage, they've never missed a treatment, and their cancer still progresses. When we only talk about cancer as a battle, we risk creating this idea that people win or lose based on effort, and that's just not how…
Not rated yetEpisode 439: Cancer Therapy for Noncancer Indications: Gene Therapies
· 39 min
"With the gene therapy itself, we collect the patient's own hematopoietic stem cells and modify them outside the body. The other approach is using a lentiviral therapy, which uses an inactivated virus to add a healthy gene, so the cells produce functional hemoglobin. While gene therapy looks a lot like an autologous stem cell transplant, the key difference is that the cells are genetically modified before they're returned to the patient," Tia T. Wheatley, DNP, RN, AGACNP-BC, TCTCN™, nurse practitioner in hematology and oncology at UCLA Health in Los Angeles, CA, told Madeline Johnston, MSN, RN, OCN®, oncology clinical specialist at ONS, during a conversation about gene therapies for sickle cell disease. Johnston also spoke to ONS member Michelle Cha, MS, BSN, RN, clinical research nurse at the Centers for Bleeding Disorders at Georgetown University Medical Center in Washington, DC, about gene therapy for hemophilia. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 30, 2027. Michelle Cha reported financial relationships with HemaBiologics, Sanofi, Acumetis Global, and Bayer, as well as research funding from multiple organizations. These financial relationships have been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to gene therapy for noncancer indications. Episode Notes - Complete this evaluation for free NCPD (https://loginlr.ons.org/sso/jwt/redirect/token?apikey=c27fb796-f5bd-43e6-91aa-59f080be0a44&jwtapp=lpuserservice&ui_locales=ons&return_url=https://login-services.ons.org/api/HttpTriggerLPuserServiceRedirect?alias=PE439). - ONS Podcast™ episodes: - Episode 433: Cancer Treatments for Noncancer Indications: Chemotherapy/Immunotherapy (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-433-cancer-treatments-noncancer-indications-chemotherapyimmunotherapy) - Episode 416: Cancer Treatments for Noncancer Indications: Radiation (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-416-cancer-treatments-noncancer-indications-radiation) - Episode 288: Pharmacology 101: Antimetabolites (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-288-pharmacology-101-antimetabolites) - Episode 286: Pharmacology 101: Alkylating Agents (https://www.ons.org/education-hub/ons-podcast) - Episode 208: How to Have Fertility Preservation Conversations With Your Patients (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-208-how-have-fertility-preservation-conversations) - Episode 173: Oncology Nurses' Role in Stem Cell Transplants for Pediatric Sickle Cell Disease (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-173-oncology-nurses-role-stem-cell-transplants) - ONS Voice articles: - Adherence to Recommended Oral Hygiene Can Help Prevent Oral Mucositis in Patients With Cancer (https://www.ons.org/publications-research/voice/news-views/11-2025/adherence-recommended-oral-hygiene-can-help-prevent) - FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer (https://www.ons.org/publications-research/voice/news-views/12-2022/fda-approves-first-adenoviral-vector-based-gene) - Fertility Preservation Protects Possibilities for Patients With Cancer (https://www.ons.org/publications-research/voice/news-views/06-2025/fertility-preservation-protects-possibilities) - New NIH Program Aims to Increase Gene Therapies for Rare Diseases (https://www.ons.org/publications-research/voice/advocacy/11-2021/new-nih-program-aims-increase-gene-therapies-rare) -…
Not rated yetEpisode 438: Inpatient Cancer Rehabilitation
· 48 min
"The question isn't simply, 'does this patient need their chemo or other cancer treatment or do they need rehabilitation?' It's often about how we can safely provide both of these things that they need. Don't assume that rehab means that cancer treatment needs to stop. The oncology and the rehabilitation teams can work with each other, especially if that starts early, and determine what we can safely coordinate," Grace Campbell, PhD, MSW, CRRN, FARN, adjunct assistant professor at the University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center in Pennsylvania, and immediate past president for the Association of Rehabilitation Nurses, told Katie Hubbard, MSN, RN, OCN®, NPD-BC, oncology clinical specialist at ONS, during a conversation about inpatient cancer rehabilitation. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 23, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to inpatient rehabilitation and its role in the care of people with cancer. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 318: Early Mobility for Hospitalized Patients - Episode 58: The Power of Cancer Rehabilitation - ONS Voice article: Cancer Rehabilitation Serves a Critical Role in Patient Care - Clinical Journal of Oncology Nursing articles: - Examining Contributors to Intent to Continue Exercising in Patients With Cancer in Rehabilitation - Physical and Psychological Effects of a 12-Session Cancer Rehabilitation Exercise Program - The Interdisciplinary Rehabilitation Care Team and the Role of Physical Therapy in Survivor Exercise - American Cancer Society: Cancer Rehabilitation - Association of Rehabilitation Nurses resources: - Cancer Rehabilitation and the Role of the Rehabilitation Nurse: A White Paper by the Association of Rehabilitation Nurses - Learning Center - Position Statement: Rehabilitation of People With Cancer (endorsed by ONS) - Contemporary Issues in Cancer Rehabilitation article: A Guide to Inpatient Cancer Rehabilitation: Focusing on Patient Selection and Evidence-Based Outcomes - ECOG: Performance Status Scale - Inpatient Rehab Versus Skilled Nursing Comparison (https://doi.org/10.5281/zenodo.23242581) - National Academies of Sciences, Engineering, and Medicine book: Diagnosing and Treating Adult Cancers and Associated Impairments - Rehabilitation Nursing Journal article: The Intersection of Rehabilitation and Palliative Care: Patients With Advanced Cancer in the Inpatient Rehabilitation Setting To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "When we talk about inpatient rehab, we're really talking about a level of rehabilitation designed for patients who have significant functional impairments, often in multiple areas of function, along with having medical, nursing, and rehabilitation needs that require an inpatient interdisciplinary environment for that sort of intensive, around-the-clock care. It's important to emphasize here that rehabilitation in general, and inpatient rehab in particular, is so much more than just getting stronger." TS 1:46 "Oncology nurses are in a great position…
Not rated yetEpisode 437: Precision Oncology: What We've Learned and What's Ahead
· 29 min
"Biomarker testing isn't just about generating more information. It's about answering very practical questions for our patients. Can we identify disease earlier? Can we understand whether treatment is working? Are we able to identify why a cancer has become resistant? Ultimately, I think that's where precision oncology becomes very meaningful. It's not about the molecular report sitting in the chart. It's about taking that information and using it to make the best possible decision for our individual patients," ONS member Erica Bello Rodriguez, MSN, AGNP, NP-C, AOCNP®, oncology nurse practitioner and supervisor of advanced practice providers at Northwell Health Cancer Institute in Westchester, NY, told Katie Hubbard, MSN, RN, OCN®, NPD-BC, oncology clinical specialist at ONS, during a conversation about precision oncology. This podcast episode was produced by ONS and is sponsored by AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes - This episode is not eligible for NCPD contact hours. - ONS Podcast™ episodes: - Episode 406: Drug Resistance Biomarkers and Their Impact on Cancer Treatment Choices - Episode 238: Cancer Genomics for Every Oncology Nurse - Episode 226: Patient Education for Next-Generation Sequencing to Guide Cancer Therapy - Episode 169: How Biomarker Testing Drives the Use of Targeted Therapies - ONS Voice articles: - An Oncology Nurse's Guide to Tumor-Agnostic Therapies - Gene Alterations in Circulating Tumor DNA Can Help Guide Treatment Decisions in Patients With Advanced Breast Cancer - Genetic Counselors Help Patients and Oncology Nurses Predict Current and Future Cancer Diagnoses - Germline and Somatic Variants: What Is the Difference? - Learn How to Read a Germline Genomic Testing Report - Learn How to Read a Somatic Biomarker Testing Report - Oncology Nurses' Role in Translating Biomarker Testing Results - Pharmacogenomics Testing Helps to Ensure That Effective Therapy Is Safe Therapy - The Oncology Nurse's Role in Identifying Patients for Cancer Genetics Counseling - What Is a Liquid Biopsy? - ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses - Clinical Journal of Oncology Nursing articles: - Pharmacogenomic Germline Testing: Applications in Oncology Nursing - Oncology Nurse Practitioners in Genetics: Examining Scope of Practice and Competence - Shifting to a Biomarker Paradigm Across Cancer Care - Using a Genomics Taxonomy: Facilitating Patient Care Safety and Quality in the Era of Precision Oncology - ONS Huddle Cards: - Genomic Biomarkers - Genomic Testing Methods - Pharmacogenomics - Referring for Germline Biomarker Testing - ONS Biomarker Guides (https://www.ons.org/clinical-tools/biomarkers) - ONS Genomics and Precision Oncology Learning Library - ONS Genomics Taxonomy (https://www.ons.org/genomics-taxonomy) - American Cancer Society: Precision or Personalized Medicine - American Society of Clinical Oncology Publications: JCO Precision Oncology - National Cancer Institute: Cancer Genomics Research To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the most important developments since 2020 have really been broader than any single variant or drug. We've seen precision oncology evolve from simply identifying a genomic alteration to developing a much more comprehensive understanding of what is driving an individual's cancer and how we can act on that information.…
Not rated yetEpisode 436: Oncologic Emergencies 101: Hypersensitivity Reactions
· 27 min
"The most important thing related to hypersensitivity reactions is that there is often a potential for rapid progression, and that's what makes these reactions an oncologic emergency. The patients may have symptoms that are mild, and that quickly can progress to respiratory compromise, hypertension, cardiovascular issues, or anaphylaxis. Early recognition is so important, so we don't want to wait for our patient to become hypotensive or significantly hypoxic before we identify that they're having a serious reaction," ONS member Christina Matousek, DNP, RN, OCN®, patient education specialist at Smilow Cancer Hospital in New Haven, CT, told Madeline Johnston, MSN, RN, OCN®, oncology clinical specialist at ONS, during a conversation about hypersensitivity reactions. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 9, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to managing hypersensitivity reactions in people receiving antineoplastic therapies. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Oncologic Emergencies 101 series (https://www.ons.org/search?ons_global%5Bquery%5D=oncologic%20emergencies%20101&ons_global%5BrefinementList%5D%5Btype%5D%5B0%5D=Podcasts) - Episode 395: Pharmacology 101: Monoclonal Antibodies (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-395-pharmacology-101-monoclonal-antibodies) - Episode 299: Pharmacology 101: Plant Alkaloids (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-299-pharmacology-101-plant-alkaloids) - Episode 286: Pharmacology 101: Alkylating Agents (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-286-pharmacology-101-alkylating-agents) - Episode 283: Desensitization Strategies to Reintroduce Treatment After an Infusion-Related Reaction (https://www.ons.org/education-hub/oncology-nursing-podcast/episode-283-desensitization-strategies-reintroduce-treatment) - ONS Voice articles: - Master Hypersensitivity Reactions With These Strategies for Prevention and Management (https://www.ons.org/publications-research/voice/news-views/05-2025/master-hypersensitivity-reactions-these-strategies) - Nurses Have Immediate Access to Necessary Medications and Supplies With Hypersensitivity Reaction Kits (https://www.ons.org/publications-research/voice/news-views/10-2022/nurses-have-immediate-access-necessary-medications) - Oncology Drug Reference Sheet: Carboplatin (https://www.ons.org/publications-research/voice/news-views/10-2025/oncology-drug-reference-sheet-carboplatin) - Oncology Drug Reference Sheet: Docetaxel (https://www.ons.org/publications-research/voice/news-views/12-2024/oncology-drug-reference-sheet-docetaxel) - Oncology Drug Reference Sheet: Paclitaxel (https://www.ons.org/publications-research/voice/news-views/09-2025/oncology-drug-reference-sheet-paclitaxel) - ONS book: Understanding and Managing Oncologic Emergencies: Traditional and Emerging (https://www.ons.org/store/books/understanding-and-managing-oncologic-emergencies-traditional-and-emerging-first-edition) - Course: ONS Oncologic Emergencies™ (https://www.ons.org/store/courses/ons-oncologic-emergencies) - Clinical Journal of Oncology Nursing articles: - Early Recognition and Response of Chemotherapy-Induced Hypersensitivity Reactions: A Nursing Discussion (https://doi.org/10.1188/26.CJON.152-155) - Prophylactic Protocol for Carboplatin Hypersensitivity in High-Risk…
Not rated yetEpisode 435: An Overview of Hodgkin Lymphoma for Oncology Nurses
· 35 min
"The accumulation of these malignant and reactive cells, that's what causes the lymph nodes to get big. That's why they grow. And that's why the classic presentation is persistent, painless, enlarged lymph nodes. So when we think of the pathophysiology of Hodgkin lymphoma, there are really two processes contributing to the presentation: One is the physical effects of enlarging lymph nodes or the involved organs. The second is the systemic inflammatory response generated by it and its surrounding immune environment," ONS member Victoria Krogg, DNP, APRN-CNP, AOCNP®, nurse practitioner at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, OH, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about an overview of Hodgkin lymphoma for oncology nurses. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 2, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the pathophysiology and diagnosis of Hodgkin lymphoma. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer - Episode 256: Cancer Symptom Management Basics: Hematologic Complications - Episode 208: How to Have Fertility Preservation Conversations With Your Patients - Episode 184: Oncologic Emergencies 101: Tumor Lysis Syndrome - ONS Voice articles: - Diabetes May Increase Hematologic Cancer Risk and Mortality - Have Meaningful Conversations With Pediatric, Adolescent, and Young Adult Patients and Their Families - Non-Hodgkin Lymphoma Symptoms, Diagnosis, Treatment, and Survivorship Recommendations - Clinical Journal of Oncology Nursing articles: - Non-Hodgkin Lymphoma: Examining Mycosis Fungoides and Sézary Syndrome in the Context of Oncology Nursing - The Unexpected Cancer Journey: Navigating Cancer as Adolescents and Young Adults - Tumor Lysis Syndrome in Solid and Hematologic Malignancies: A Guide for Early Detection and Intervention - ONS Huddle Cards: - Fertility Preservation - Oncogenic Viruses - Tumor Lysis Syndrome - ONS Symptom Management Resource: Fatigue - Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library - Blood Cancer United: Hodgkin Lymphoma - Lymphoma Research Foundation: Hodgkin Lymphoma - National Comprehensive Cancer Network (https://www.nccn.org/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Hodgkin lymphoma can be diagnosed at virtually any age but is more common in younger patients as well as older adults. It kind of skips middle-aged people, but it occurs in our geriatric population as well. There are different prognostic implications depending on the group of patients that are diagnosed with Hodgkin lymphoma. As far as risk factors ... Hodgkin lymphoma is not considered a hereditary disease. There's not a specific gene we know of today that can be passed down to children and put them at risk. But if there is a first-degree relative affected by a lymphoma, we do find that noteworthy. We do consider it a risk factor. But that risk factor…
Not rated yetEpisode 434: Oncology–Psychiatric RN Collaboration to Support Psychosocial Health
· 34 min
"Nurses are the front line. Oncology nurses see their patients almost all day. If you're noticing that anxiety is causing significant distress or anxiety is disrupting a patient's ability to concentrate during medical conversations or decision-making—anytime you're seeing significant distress or disruption to functioning, that's a pretty good indicator that referral to a psychiatric nurse and psychiatric care could be very helpful for that patient," Amber Altidor, DNP, APRN-FPA, PMHNP-BC, assistant professor at Rush University College of Nursing and psychiatric nurse practitioner at Optimal Mental Health PLLC and Rush MD Anderson Cancer Center in Chicago, IL, told Katie Hubbard, MSN, RN, OCN®, NPD-BC, oncology clinical specialist at ONS, during a conversation about oncology and psychiatric nurse collaboration to support psychosocial health. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), by listening to the full recording and completing an evaluation at courses.ons.org by September 25, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge of how oncology nurses can collaborate with psychiatric nurses to support the psychosocial health of people with cancer. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 426: Tools to Support Patients and Nurses Through Medical Trauma in Oncology - Episode 421: Medical Trauma in Oncology - Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care - Episode 240: Spirituality in Cancer Care - Episode 219: Use Acupuncture and Acupressure to Manage Cancer Symptoms and Side Effects - ONS Voice articles: - Anxiety and Depression Are Biggest Concerns for Patients With Cancer, Survivors, Caregivers - AYA Cancer Survivors Experience Five Times Higher Depression Rates Than Individuals Diagnosed at Older Ages - Guidelines Define the Role of Integrative Oncology Care for Managing Anxiety and Depression in Adults With Cancer - Natural Language Processing Can Tell You Which Patients May Benefit From Psychosocial Referrals - Physical Activity, Psychological Care Reduce Cancer-Related Fatigue - What Assessment Tools Are Used for Patients With Cancer and Psychiatric Diagnoses? - ONS course: Psychosocial Dimensions of Cancer Care™ - Clinical Journal of Oncology Nursing articles: - Psychosocial Barriers to Care: Recognizing and Responding Through a Trauma-Informed Care Approach - Psychosocial Distress Screening: An Educational Program's Impact on Participants' Goals for Screening Implementation in Routine Cancer Care - Oncology Nursing Forum articles: - Effects of Expressive Writing on Psychosocial Symptoms and Quality of Life in Patients With Breast Cancer: A Systematic Review and Meta-Analysis - Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers - The Distress Thermometer: Cutoff Points and Clinical Use - ONS Symptom Management Resources: - Anxiety - Depression - Fatigue - ONS Coping Huddle Card - American Cancer Society: Therapy, Counseling, and Support Resources for People With Cancer - American Psychological Association: Patient Health Questionnaire-9 (PHQ-9) - American Psychosocial Oncology Society: - Distress Screening - Resources for Psychosocial Oncology Professionals (https://apos-society.org/member-resources/) - Columbia-Suicide Severity Rating Scale (C-SSRS) - Generalized Anxiety Disorder 7-Item (GAD-7) Scale - National Comprehensive Cancer Network…
Not rated yetEpisode 433: Cancer Treatments for Noncancer Indications: Chemotherapy/Immunotherapy
· 33 min
"Unlike our cancer indications where we use these medications often to activate the immune system to target cancerous cells, in noncancer indications, the goal is really to either suppress an overactive immune or inflammatory cells or modulate the immune system. Immune modulation by use of chemotherapy and immunotherapy can help reduce abnormal inflammation, decrease autoantibody production, and also can alter T-cell and B-cell activity," ONS member Kelsey Miller, MSN, RN, AGCNS-BC, OCN®, clinical nurse specialist in oncology and infusion therapy at Reading Hospital in West Reading, PA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about chemotherapy and immunotherapy for noncancer indications. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of anticancer therapies for noncancer indications. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Pharmacology 101 series - Episode 152: Administer Rituximab Immunotherapy With Confidence - ONS Voice articles: - JAK1 Inhibitor Quickly Relieves ICI-Related Dermatitis - Oncology Drug Reference Sheet: Cyclophosphamide - Oncology Drug Reference Sheet: Methotrexate - What Oncology Nurses Need to Know About Arboviral Disease in Patients Receiving B-Cell–Depleting or –Modulating Therapies - ONS books: - Access Device Guidelines: Recommendations for Nursing Practice and Education (fourth edition) - Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) - Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) - Clinical Journal of Oncology Nursing article: Early Recognition and Response of Chemotherapy-Induced Hypersensitivity Reactions: A Nursing Discussion - ONS courses: - ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ - Safe Handling Basics - Vascular Access Devices - ONS Huddle Cards: - Anaphylaxis - Monoclonal Antibodies - ONS position statement: Education of the Nurse Who Administers and Cares for the Individual Receiving Antineoplastic Therapies - American Academy of Neurology: Practice Guideline Recommendations: Disease-Modifying Therapies for Adults With Multiple Sclerosis - American College of Rheumatology: Treatments - National Multiple Sclerosis Society: - Infused therapies - Injectable therapies - Medications Used Off-Label - NCODA Patient Education Sheets (https://patienteducationsheets.com/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The most common immunotherapy agent that's well known to both oncology and other autoimmune disorders is rituximab. And that is used for rheumatoid arthritis, granulomatous, and antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. And then it also has many off-label indications for other autoimmune disorders, such as lupus and multiple sclerosis. It's also used in immune thrombocytopenia and Sjogren's condition." TS 3:28 "Two common chemotherapy agents that come to mind that are used in…
Not rated yetEpisode 432: Long-Term Chronic Lymphocytic Leukemia Considerations for Oncology Nurses
· 31 min
"It's a chronic disease. It never goes away for some people, and so therefore it has these periods of remission where it's really quiet and well controlled. Then there can be periods of flares where you're actively engaged in treatment or it's impacting other pieces. There's this feeling patients have of, 'When am I going to have that flare?' You know, this anticipatory anxiety of, 'When are things going to be done differently?' or 'When do I need to change?'" ONS member Caitlin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term chronic lymphocytic leukemia (CLL) considerations for oncology nurses. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 15 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by September 11, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the nursing considerations of caring for people with long-term CLL. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 428: Chronic Lymphocytic Leukemia Treatment Considerations for Oncology Nurses - Episode 422: An Overview of Chronic Lymphocytic Leukemia for Oncology Nurses - Episode 256: Cancer Symptom Management Basics: Hematologic Complications - Episode 201: Which Survivorship Care Model Is Right for Your Patient? - ONS Voice articles: - Cardio-Oncology Program Monitors Heart Toxicities Throughout Survivorship - Fixed-Duration Therapy for CLL May Lower Cardiovascular Risks and Costs Less Than Continuous Treatment - Individuals With CLL Face Increased Risk for Skin Cancer - Patients With CLL Report Worse QoL and Other Factors - Clinical Journal of Oncology Nursing articles: - In Remission: A Patient's Experience of Continued Care After Chronic Lymphocytic Leukemia - Venetoclax: Management and Care for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - ONS book: Site-Specific Cancer Series: Leukemia (first edition) - ONS Learning Libraries: - Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library - Survivorship Learning Library - ONS Symptom Management Resources: - Prevention of Bleeding - Prevention of Infection: General - CLL Society: Living With CLL (https://cllsociety.org/living-with-cll-home/) - Lymphoma Research Foundation: Remission and Long-Term Survivorship - National Comprehensive Cancer Network (https://www.nccn.org/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "I think about the immunocompromised state that often comes from the CD20 monoclonal antibodies such as obinutuzumab, rituximab, and ofatumumab. All of those are agents that have been used in CLL, and they can lead to hypogammaglobulinemia. That is something that can be short-lived right after therapy, but can be prolonged or even a lifelong status after receiving these types of therapies. And then some of the other pieces that we think about are increased risk of basal cell carcinoma, routine skin exams, and maintaining some of those components of…
Not rated yetEpisode 431: Oncologic Emergencies 101: Urinary Obstruction
· 19 min
"Think about all the important things our kidneys do for the body. Those things are compromised. If we have excess buildup of toxins and waste in the body, you're having problems with fluid reabsorption. Then you have also problems with electrolytes not being balanced. Then in turn, you have ongoing shutdown of systems. So the cardiopulmonary system gets compromise. Your circulatory system then gets compromised. And then all the things in the body that depend upon ongoing circulatory flow are then causing major resets in the system that need to be addressed," ONS member Brenda S. Nettles, DNP, MS, ACNP-BC, AOCNP, CNE, assistant professor at the Johns Hopkins School of Nursing and nurse practitioner at Johns Hopkins Hospital in Baltimore, MD, told Madeline Johnston, MSN, RN, OCN®, oncology clinical specialist at ONS, during a conversation about urinary obstructions. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 4, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge relating to urinary obstruction as an oncologic emergency. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Oncologic Emergencies 101 series - Episode 424: Radiation Site-Specific Side Effects: Cancers of the Pelvis - Episode 394: Prostate Cancer Survivorship Considerations for Nurses - Episode 390: Prostate Cancer Treatment Considerations for Nurses - Episode 387: Prostate Cancer Screening, Early Detection, and Disparities - ONS Voice articles: - A Primer on Urothelial Cancer - Oncology Urgent Care Provides the Right Place, Right Time, and Right Treatment for Patients Experiencing Cancer-Related Emergencies - In the Event of an Oncologic Emergency, Make Sure You're Prepared to Deliver Compassionate, Life-Saving Care - ONS book: Understanding and Managing Oncologic Emergencies: Traditional and Emerging - ONS course: ONS Oncologic Emergencies™ - ONS Oncologic Emergencies Learning Library - American Cancer Society anatomy galleries: - Female Genitourinary System - Male Genitourinary System To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "As far as diagnoses go, I think that the ones that we see most common are impacted by the actual genitourinary system itself being impacted, so your patients with prostate cancer and patients with bladder cancer are definitely the ones that we see most often. But you'll see that it's also in individuals that have a diagnosis of either mucinous neoplasms or invasive peritoneal disease that invades all the cavities of the body—and also your sarcomas, because they also will actually the involve different parts of the renal system as part of their spread pattern." TS 3:55 "The first thing you want to do is try to eliminate the causative factor. So what's causing the obstruction? If there's something that's limiting flow because of the compression from the outside of the ureter or compressing around the kidney itself that they can't drain adequately, then you can look at ways to manage that by inserting a nephrostomy tube into the kidney. You can also put in ureteral stents to help alleviate the pressure from drainage…
Not rated yetEpisode 430: Leadership Unlocked: Is It Your Time to Serve?
· 34 min
"If you are considering board service, I would say take the leap. Start with your local chapter. It will give you some valuable skills that will help prepare you when you are applying for your national level. And I always say, if you want to do it, just do it because what's the worst that can happen? They can say no, but that doesn't mean that you will never serve on a board. I always tell people delayed is not denied," Cassandra Green, DNP, RN, OCN®, ONS member and past president of the Oncology Nursing Certification Corporation (ONCC) Board of Directors, told Evelyn Wempe, DNP, MBA, APRN, ACNP-BC, AOCNP®, CRN, NEA-BC, chair of the ONS Leadership Succession Committee (formerly known as the Leadership Development Committee), during a conversation about service on a board of directors. Wempe spoke with Green and ONS members Kristin Ferguson, DNP, MBA, RN, OCN®, CGNC, former treasurer and director-at-large on the ONS Board of Directors, and Yanka Campbell, DNP, RN, CPHQ, AGPCNP-BC, CNE, member of the Oncology Nursing Foundation (ONF) Board of Directors, about their experiences with board service. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 28, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to serving on a board of directors for a professional organization. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Meet the ONS Board of Directors series - Episode 342: What It's Like to Serve on the Leadership Development Committee - ONS Voice articles: - Could Today Be the Start of Your ONS Leadership Journey? - Nursing Leadership Unlocked - Leading With Purpose Creates a Vision for the Future of Oncology Nursing - ONS courses: - A Guide to Chapter Leadership: Chapter President Training - Board Leadership: Nurses in Governance - Clinical Journal of Oncology Nursing article: Rearview Mirror Leadership: Looking Backward to Move Forward - ONS Board Self-Assessment - ONS Leadership - ONCC Board of Directors (https://www.oncc.org/about-oncc/leadership) - ONF Leadership - Your Roadmap to Future Service on the ONS Board of Directors - ONS Leadership Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Campbell: "Joining a board was a natural next step for me to maintain my connection to bedside nursing that I've loved for so many years, and to find a way to give back to advanced practice nurses as well in this role. The Oncology Nursing Society and Foundation were especially meaningful for me because I knew firsthand the importance of having scholarship, research, funding, and leadership development programs that can really change the trajectory of a nurse's career. I realized I wanted to help shape the opportunities that were available to me for future nurses, and I just did not want to continue to do that through one-on-one mentorships, which I have done extensively throughout my career, but find a way to help more broadly toward guiding organizational mission and strategic objectives." TS 7:20 Green: "Everyone was so welcoming on the board. Everyone was so friendly. One of the first things I…
Not rated yetEpisode 429: Radiation Site-Specific Side Effects: CNS Cancers
· 36 min
"They're really worried that radiation is going to be painful. So they come in for that first day of treatment very anxious. With our patients with brain cancer, we're using the masks on the table, and those masks are very tight and hold their heads very, very still. So they'll be very worried about being claustrophobic. We may start out the first day or two with a little bit of [lorazepam]. And they'll come to me and they'll say, 'This really hasn't been as bad as I thought it was going to be,'" ONS member Catherine McCluskey, BSN, RN, OCN®, ROCN™, radiation oncology staff nurse at Atrium Health Wake Forest Baptist in Winston-Salem, NC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, who was the manager of oncology nursing practice at ONS at the time of the recording, during a conversation about radiation side effects in central nervous system (CNS) cancers. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 21, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat CNS cancer. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Radiation Site-Specific Side Effects series - Episode 306: Cancer Symptom Management Basics: CNS Toxicities - ONS Voice articles: - Augmented Reality Simulations Reduce Patient Anxiety by Teaching Them About Radiation Therapy - CNS Survivorship Needs More Research, Funding, and Training, Expert Panel Says - Here's What the Updated CTCAE Version 6.0 Means for Oncology Nurses - Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education - Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects - ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) - ONS courses: - Indications of Targeted Radiotherapy to the Brain and Spine: 2025 ONS Congress® Session - ONS ROCN™ Certification Review™ - ONS/ONCC® Radiation Therapy Certificate™ - Supporting Radiation Side Effect Management Through ONS Evidence-Based Resources: 2025 ONS Congress® Session - Clinical Journal of Oncology Nursing articles: - Implementing a Standardized Educational Tool for Patients With Brain Tumors Undergoing Concurrent Temozolomide and Radiation Therapy (https://doi.org/10.1188/24.CJON.477-482) - Radiation Necrosis: A Differential Diagnosis Dilemma (https://doi.org/10.1188/26.CJON.181-185) - The Neurocognitive Late Effects of Cranial Radiation Therapy: The Often-Unrecognized Outcomes (https://doi.org/10.1188/26.CJON.175-180) - Oncology Nursing Forum article: Symptom Clusters in Patients With Brain Tumors Undergoing Proton Beam Therapy - ONS Huddle Cards: - External Beam Radiation - Proton Therapy Proton Therapy - Radiation - ONS Guidelines™ and Symptom Management Resources - Cognitive impairment - Fatigue - Mucositis - Radiodermatitis - ONCC resources: - Big List of CE (https://www.oncc.org/big-list) - Radiation Oncology Certified Nurse (ROCN™) - Common Terminology Criteria for Adverse Events (CTCAE v6.0) - Patient Health Questionnaire (PHQ-9 and PHQ-2) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.…
Not rated yetEpisode 428: Chronic Lymphocytic Leukemia Treatment Considerations for Oncology Nurses
· 49 min
"Measurable residual disease is where I think the terminology fits best in that, it is intended to measure the amount of cancer cells that are present in the blood or bone marrow at the time the sample was collected. We can identify one cancer cell in a million. Where that can be really valuable is when we start to think about the duration of treatments and the response to some of our treatments," ONS member Caitlin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about chronic lymphocytic leukemia (CLL) treatment considerations for oncology nurses. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD), including 45 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by August 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to treatment of chronic lymphocytic leukemia. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 422: An Overview of Chronic Lymphocytic Leukemia for Oncology Nurses - Episode 256: Cancer Symptom Management Basics: Hematologic Complications - Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis - Episode 184: Oncologic Emergencies 101: Tumor Lysis Syndrome - ONS Voice articles: - Fixed-Duration Therapy for CLL May Lower Cardiovascular Risks and Costs Less Than Continuous Treatment - Individuals With CLL Face Increased Risk for Skin Cancer - Master Hypersensitivity Reactions With These Strategies for Prevention and Management - Patients With CLL Report Worse QoL and Other Factors - Clinical Journal of Oncology Nursing articles: - Acalabrutinib: Nursing Considerations for Use in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Pseudohyperkalemia in Chronic Lymphocytic Leukemia: An Often Overlooked Clinical Entity - Richter Transformation Arising From Chronic Lymphocytic Leukemia - Venetoclax: Management and Care for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - ONS book: Site-Specific Cancer Series: Leukemia (first edition) - ONS symptom management resources: - Fatigue - Prevention of Bleeding - Prevention of Infection: General - Blood Cancer United: Chronic Lymphocytic Leukemia Treatment - CLL Society: Patient Education Toolkit - Lymphoma Research Foundation: Lymphoma Treatments - Patient education sheets - Acalabrutinib - Ibrutinib (https://ncoda.org/pes/ibrutinib/) - Pirtobrutinib To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Blood work is a really nice way to evaluate if there is progression of the disease. And we evaluate their blood counts, specifically that complete blood count with a differential. We anticipate an elevated white count, and we anticipate that the absolute lymphocyte count is going to be elevated. That's characteristic of the disease. But what evolves and happens is that those numbers can rapidly change and what we get concerned about is if that white count—and the percentage of the absolute lymphocyte count specifically—starts to increase and double…
Not rated yetEpisode 427: Pharmacology 101: Resistance Pathways
· 29 min
"A good way of thinking about this is this is the survival of the fittest clone. There could be a portion of a cancer that naturally has some resistance or ability to survive a particular drug. And over time, as the other cells around it are dying off, that particular clone is able to replicate and continue to survive in the face of that drug therapy and eventually take over as being the fittest clone. At that point, we're often seeing disease progression," Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about resistance pathways. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 30 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by August 7, 2027. Roman has served on advisory boards for Genetech, Pfizer, Regeneron, and Daiichi Sankyo and received honoraria payments from Pharmacy Times and Decera for faculty lectures. These financial relationships have been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge related to resistance pathways in oncology care. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Pharmacology 101 series - Episode 423: Pharmacology 101: Interaction Pathways - Episode 406: Drug Resistance Biomarkers and Their Impact on Cancer Treatment Choices - ONS Voice articles: - Predictive and Diagnostic Biomarkers - Scientists Identify Protein Implicated in Tumor Growth, Treatment Resistance - ONS book: Guide to Cancer Immunotherapy (second edition) - Genomics and Precision Oncology Learning Library - ONS Biomarker Database (https://www.ons.org/clinical-tools/biomarkers) - Pharmacogenomics Huddle Card - CancerQuest: Cancer Drug Resistance - National Comprehensive Cancer Network (https://www.nccn.org/) - OncoKB.org (https://www.oncokb.org/) - Research To Practice (https://researchtopractice.com/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "As we look at drug resistance, this is the concept that cancer cells are no longer able to respond to a cancer treatment. The downstream of this is that we could end up with progression of the disease and need to look at alternative therapies that may be beneficial for the patient. This is unfortunately a very common phenomenon. Drug resistance is a major cause of treatment failure and poor patient outcomes with treatments. Unfortunately, this is an issue we see that increases over time on treatment." TS 2:29 "Genetics play a really big role in drug resistance. We know that drug resistance can be due to different things. It could be epigenetics. It could be the tumor microenvironment factors. But genetics often play a very big role in resistance pathways. It's generally considered to be a critical contributor to resistance, particularly in the way of acquired variants to drug targets or amplifications of certain oncogenes that can lead cancers to have progression. A well-known genetic alteration is the BRCA1/BRCA2 variant that helps to make the cancer more efficient at fixing DNA damage. So we're trying to get DNA damage with chemotherapy, and this particular variant helps at fixing that damage…
Not rated yetEpisode 426: Tools to Support Patients and Nurses Through Medical Trauma in Oncology
· 42 min
"When people with PTSD [post-traumatic stress disorder] get quite avoidant—and that can be expressed in so many different ways—the implications can be really profound. I think an important invitation to oncologists and oncology nurses and primary care providers who care for people battling cancer is let's explore what's underneath these avoidant behaviors. Is it a very practical thing? Or is it that underneath this avoidant behavior is really profound fear?" James C. Jackson, PsyD, research professor at Vanderbilt University Medical Center in Nashville, TN, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about addressing medical trauma in oncology. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 31, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to medical trauma in oncology care. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 421: Medical Trauma in Oncology - Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care - Episode 264: Stop the Stressors and Improve Your Mental Health as a Nurse - ONS Voice articles: - Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD [post-traumatic stress disorder] - Past Trauma Lowers Hope, QOL, and Coping Ability During Cancer - Managing Cancer-Related PTSD Starts With Acknowledgement - Moral Injury and Trauma in Nursing - Trauma-Informed Care Provides Person-Centered Support for Patients During Deep Distress - Clinical Journal of Oncology Nursing articles: - How Can a Trauma-Informed Care Approach Be Applied to Patients With Gynecologic Cancer? - Psychosocial Barriers to Care: Recognizing and Responding Through a Trauma-Informed Care Approach - Oncology Nursing Forum articles: - Post-Traumatic Distress and Symptom Experience in Patients With Head and Neck Cancer–Related Tracheostomy and Family Caregivers - The Effect of Neuroticism, Fear of Progression, and Self-Efficacy on Post-Traumatic Growth in Patients With Lung Cancer Undergoing Chemotherapy - The Relationship Between Colorectal Cancer Survivors' Positive Psychology, Symptom Characteristics, and Prior Trauma During Acute Cancer Survivorship - ONS course: Psychosocial Dimensions of Cancer Care™ - ONS Huddle Card: Coping - Screening tools - Clinician-Administered PTSD Scale for DSM-5 [Diagnostic and Statistical Manual of Mental Disorders, 5th edition] (CAPS-5) - Hospital Anxiety and Depression Scale - Primary Care PTSD Screen for DSM-5 - PTSD Checklist for DSM-5 - Trauma Screening Questionnaire (https://doi.org/10.1192/bjp.181.2.158) - International Society for Traumatic Stress Studies: Free Resources - PESI (https://www.pesi.com/) - Reclaiming Your Life From Medical Trauma by James C. Jackson To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "For many people who have been traumatized, if they can avoid it, they will. They may not avoid the annual evaluation that is so hugely consequential—they might not avoid that. But they may well avoid a routine visit for a checkup to…
Not rated yetEpisode 425: How AI Can Help Healthcare Organizations Improve the Cancer Experience
· 29 min
"In oncology specifically, where care is complex, artificial intelligence (AI) can really synthesize large volumes of clinical information, flag risks such as treatment complications, and support adherence to evidence-based pathways. For nurses specifically, this enables them more time for direct patient care, clinical judgment, and care coordination, and really practice to the top of their license while reducing repetitive time and administrative tasks," Jenn Frith, DNP, RN, OCN®, NE-BC, associate vice president of clinical operations at Duke Cancer Institute in Durham, NC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS. Weimer spoke with Frith and Emily Norboge, director of clinical and research informatics at Duke Cancer Institute, about how AI can help healthcare organizations improve the cancer experience. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 24, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of artificial intelligence in oncology nursing practice. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 284: How AI Is Influencing Cancer Care and Oncology Nursing - Episode 281: Nursing's Role in AI in Health Care - ONS Voice articles: - Human Connection Creates the Power Behind AI in Nursing - If You're Using AI in Health Care, Your Patients Want to Know - Majority of Adults Use AI, But Most Distrust Accuracy of Health Information - Nurses Are Key to Quality for AI Tools in Oncology Care - One-Third of Hospitals Have Integrated Generative AI Into EHRs, With More to Follow - Clinical Journal of Oncology Nursing articles: - A Case for Caution: Patient Use of Artificial Intelligence - Artificial Intelligence in Oncology Nursing: Preparing the Workforce for the Future - Artificial Intelligence: Basics, Impact, and How Nurses Can Contribute - Integrating Artificial Intelligence Into Cancer Care: Enhancing Nursing Practice and Bridging Disparities - Oncology Nursing Forum article: Artificial Intelligence for Oncology Nursing Authors: Potential Utility and Concerns About Large Language Model Chatbots To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Norboge: "Our AI voice agent has a series of workflows that it can execute. ... If a patient needs help with medical paperwork, the agent will walk the patient through how to do that paperwork. If a patient has a question that they need sent to their provider, it can document that and then send a message to the provider. There's a series of workflows so it can route to scheduling. It can answer information about test results that is compliant with our policy around test results. The goal of that agent is that it will handle all of those administrative-type tasks that don't necessarily require a nurse to fill." TS 5:44 Norboge: "When [patients] call the nurse triage line, the nurse will have to say, 'I understand you want your test results. I can contact your provider and have them reach out to you about your results.' But that's kind of where it ends. What we worked out with the agent is if a patient…
Not rated yetEpisode 424: Radiation Site-Specific Side Effects: Cancers of the Pelvis
· 47 min
"Think about what organs lie in the radiation field, and anything that lies in that radiation field is likely going to have some potential temporary—hopefully temporary—side effects. If you think about the pelvis, the things that live in there are the bladder, urethra, some bowel, rectum, reproductive organs, skin, some lymph nodes. And so, all of those things could potentially have associated side effects," ONS member Kayla Kafka-Peterson, BSN, RN, ROCN™, nurse navigator and leader in the brachytherapy and peri-anesthesia programs at UCLA Health, in Los Angeles, CA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about radiation side effects in cancers of the pelvis. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 17, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to radiation to the pelvis. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Radiation Site-Specific Side Effects series - Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices - Episode 298: Radiation Oncology: Nursing's Essential Roles - ONS Voice articles: - Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education - The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management - ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) - ONS courses: - Nurse Navigation and Care During Brachytherapy for Cervical Cancer: 2025 ONS Bridge™ Session - ONS ROCN™ Certification Review™ - ONS/ONCC® Radiation Therapy Certificate™ - Clinical Journal of Oncology Nursing articles: - Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society (https://doi.org/10.1188/25.CJON.48-59) - Genitourinary Distress: Common Side Effect (https://doi.org/10.1188/21.CJON.S2.27) - Sexual Dysfunction: Common Side Effect (https://doi.org/10.1188/21.CJON.S2.16-20) - Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers (https://doi.org/10.1188/21.CJON.321-328) - Oncology Nursing Forum article: Effect of Foot Reflexology and Aromatherapy on Anxiety and Pain During Brachytherapy for Cervical Cancer - ONS Guidelines™ and Symptom Management Resources: - Radiodermatitis - Radiation-Induced Diarrhea - Brachytherapy Huddle Card - American Brachytherapy Society (https://www.americanbrachytherapy.org/) - American Society for Radiation Oncology (https://www.astro.org/) (ASTRO) - European Society for Radiotherapy and Oncology (https://www.estro.org/) (ESTRO) - GEC-ESTRO Committee - International Gynecologic Cancer Society (https://igcs.org/) - Nursing Certificate Program To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Brachytherapy is delivered two main ways. The most common is LDR and HDR. LDR stands for low-dose-rate radiation, which is the older type of brachytherapy, but it is still very much practiced today. And it is where we put radioactive seeds directly into the tumor or tumor…
Not rated yetEpisode 423: Pharmacology 101: Interaction Pathways
· 30 min
"When we think of drug interactions, specifically, the National Cancer Institute actually defines this as a change in the way a drug acts in the body when taken with certain other drugs, herbals, or foods or when taken with certain medical conditions. Drug interactions may cause the drug to either be more or less effective or cause effects on the body that are not expected," Carissa Ganihong, PharmD, BCOP, oncology and bone marrow transplantation clinical pharmacist at Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about interaction pathways. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 30 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by July 10, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge related to drug interactions in oncology care. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: Pharmacology 101 series - ONS Voice articles: - Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs? - Pharmacogenomics Testing Helps to Ensure That Effective Therapy Is Safe Therapy - Use of Herbal Products Carries Risk for Drug Interactions, but Patient–Clinician Knowledge, Communication Remain Low - What the Research Says About Drug Interactions and Medical Cannabis - ONS books: - Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) - Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) - ONS Huddle Cards: - DPYD Gene and DPD Enzyme - Pharmacogenomics - ONS Oral Anticancer Medication Toolkit - American Journal of Nursing articles: - Understanding Pharmacokinetics: Part1: Drug Absorption - Understanding Pharmacokinetics: Part 2: Drug Distribution - Understanding Pharmacokinetics: Part 3: Drug Metabolism - Understanding Pharmacokinetics: Part 4: Drug Elimination - Journal of Nuclear Medicine Technology articles: - Pharmacology, Part 1: Introduction to Pharmacology and Pharmacodynamics (https://doi.org/10.2967/jnmt.117.199588) - Pharmacology, Part 2: Introduction to Pharmacokinetics (https://doi.org/10.2967/jnmt.117.199638) - ClinPGx (https://www.clinpgx.org/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "One of the most notable food interactions that interacts with many different medications is actually grapefruit or grapefruit juice. This is known to be a very strong CYP3A4 inhibitor. … A lot of medications are metabolized through the CYP3A4 pathway. By inhibiting the effect of these enzymes, that can actually increase and significantly increase the concentrations of these therapies. It's not an interaction that's just limited to grapefruit. I would say grapefruit being in the food interaction is kind of one of the most well-known, but it can also be seen with other foods as well, like pomegranate juice or a very specific type of orange called Seville oranges. And this is really just due to the presence of a substance called furanocoumarins." TS 6:12 "There have been a pretty large number of genes identified that are responsible for coding some of…
Not rated yetEpisode 422: An Overview of Chronic Lymphocytic Leukemia for Oncology Nurses
· 47 min
"What I appreciate about our patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia is the consideration that they receive a cancer diagnosis, and the best thing for them to do is actually nothing. There is a large population of patients that we don't recommend any type of treatment. We recommend that they establish care with an oncologist and that they have a relationship with those care teams," ONS member Caitlin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about an overview of CLL for oncology nurses. Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 3, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge of the diagnosis and management of chronic lymphocytic leukemia. Episode Notes - Complete this evaluation for free NCPD. - ONS Podcast™ episodes: - Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer - Episode 256: Cancer Symptom Management Basics: Hematologic Complications - ONS Voice articles: - Compensation Funds Curb Financial Burden for Certain Exposure-Related Cancers - Infection Prevention for Oncology Nurses - Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment - Patient Stress Linked to More Advanced Leukemia - Patients With CLL Report Worse QoL and Other Factors - Clinical Journal of Oncology Nursing articles: - Care Coordination: Overcoming Barriers to Improve Outcomes for Patients With Hematologic Malignancies in Rural Settings - Pseudohyperkalemia in Chronic Lymphocytic Leukemia: An Often Overlooked Clinical Entity - Richter Transformation Arising From Chronic Lymphocytic Leukemia - ONS book: Site-Specific Cancer Series: Leukemia (first edition) - Hematology, Cellular Therapy and Stem Cell Transplantation Learning Library - ONS Biomarker Database (https://www.ons.org/clinical-tools/biomarkers) - ONS clinical practice resource: Genomics Taxonomy - Blood Cancer United: Chronic Lymphocytic Leukemia: In Detail - CLL Society: Patient Education Toolkit - Lymphoma Research Foundation: Lymphoma and CLL Publications - National Comprehensive Cancer Network (https://www.nccn.org/) To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/). To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the common risk factors are environmental exposures, occupational exposures, and chemical exposures. For example, in certain farming communities where there are pesticides, that can definitely contribute to the risk of developing CLL. There's some consideration for high levels of radon exposure or exposure to Agent Orange. So our veterans, both from the Vietnam War but also more recently in Iraq. There's definitely a consideration that those types of exposures increase the risk of developing CLL." TS 3:01 "Generally, the average age of diagnosis for CLL is in the seventh decade of life. But over 90% of people are diagnosed at age 50 and above. So, this tends to be a diagnosis in the six or seventh decade of life. It's extremely rare in children, although it has been observed, and…
Not rated yet